BioCentury
ARTICLE | Financial News

Microlin pulls IPO

September 20, 2014 1:27 AM UTC

Microlin Bio Inc. (New York, N.Y.) withdrew its IPO on NASDAQ, citing market conditions. In June the company amended its IPO to sell 5.5 million units consisting of one share and one warrant at $4.50-$5.50. At $5, the company would have raised $27.5 million and been valued at $51.3 million. Brean Capital; Summer Street; and Meyers Associates were underwriters. In January, the company filed to raise $25 million with Sunrise Securities as the sole underwriter. As of Sept. 30, 2013, Microlin had no cash. ...